The DOI matches its Crossref record; 119 of the 121 references it cites were found in a registry or an index.
Biochemical Verification of Tobacco Use and Abstinence: 2019 Update
Open accessAbstract
BACKGROUND: The changing prevalence and patterns of tobacco use, the advent of novel nicotine delivery devices, and the development of new biomarkers prompted an update of the 2002 Society for Research on Nicotine and Tobacco (SRNT) report on whether and how to apply biomarker verification for tobacco use and abstinence. METHODS: The SRNT Treatment Research Network convened a group of investigators with expertise in tobacco biomarkers to update the recommendations of the 2002 SNRT Biochemical Verification Report. RESULTS: Biochemical verification of tobacco use and abstinence increases scientific rigor and is recommended in clinical trials of smoking cessation, when feasible. Sources, appropriate biospecimens, cutpoints, time of detection windows and analytic methods for carbon monoxide, cotinine (including over the counter tests), total nicotine equivalents, minor tobacco alkaloids, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol are reviewed, as well as biochemical approaches to distinguishing cigarette smoking from use of electronic nicotine delivery devices (ENDS). CONCLUSIONS: Recommendations are provided for whether and how to use biochemical verification of tobacco use and abstinence. Guidelines are provided on which biomarkers to use, which biospecimens to use, optimal cutpoints, time windows to detection, and methodology for biochemical verifications. Use of combinations of biomarkers is recommended for assessment of ENDS use. IMPLICATIONS: Biochemical verification increases scientific rigor, but there are drawbacks that need to be assessed to determine whether the benefits of biochemical verification outweigh the costs, including the cost of the assays, the feasibility of sample collection, the ability to draw clear conclusions based on the duration of abstinence, and the variability of the assay within the study population. This paper provides updated recommendations from the 2002 SRNT report on whether and how to use biochemical markers in determining tobacco use and abstinence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“authors like Benowitz et al. (2020) and West et al. (2005) suggest that abstinence outcomes are also reliable in those studies in which biochemical verification is not feasible, such as those in which the data are collected by phone or through the internet or when personal contact is limited.”
From Evaluation of effectiveness and acceptability of a psychological treatment for smoking cessation combined with a smartphone App: A pilot study (2024) · cites this paper as Benowitz et al., 2020
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,766
Current Cigarette Smoking Among Adults — United States, 2005–2014
Jamal, A., Homa, D. M., O’Connor, E., Babb, S. D., Caraballo, R. S., Singh, T., Hu, S., & King, B. A. (2015) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6444a2 · Cited by 2,544
Biochemical verification of tobacco use and cessation
Benowitz, N. L., III, P. J., Ahijevych, K., Jarvis, M. J., Hall, S., LeHouezec, J., Hansson, A., Lichtenstein, E., Henningfield, J., Tsoh, J., et al. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200210123581 · Cited by 1,800
Self-citationThe validity of self-reported smoking: a review and meta-analysis.
Patrick, D. L., Cheadle, A. D., Thompson, D. C., Diehr, P. H., Koepsell, T. D., & Kinne, S. (1994) · American Journal of Public Health · doi:10.2105/ajph.84.7.1086 · Cited by 1,737
Metabolism and Disposition Kinetics of Nicotine
Hukkanen, J., Jacob, P., & Benowitz, N. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.3 · Cited by 1,583
Self-citationAnthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., Ascher, J., Russ, C., Krishen, A., & Evins, A. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30272-0 · Cited by 1,177
Self-citationBiochemistry, Biology, and Carcinogenicity of Tobacco-Specific N -Nitrosamines
Hecht, S. S. (1998) · Chemical Research in Toxicology · doi:10.1021/tx980005y · Cited by 1,074
Self-citationComparison of tests used to distinguish smokers from nonsmokers
Jarvis, M. J., Tunstall-Pedoe, H., Feyerabend, C., Vesey, C., & Saloojee, Y. (1987) · American Journal of Public Health · doi:10.2105/ajph.77.11.1435 · Cited by 994
Self-citationCurrent Cigarette Smoking Among Adults — United States, 2005–2015
Jamal, A., King, B. A., Neff, L. J., Whitmill, J., Babb, S. D., & Graffunder, C. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6544a2 · Cited by 920
Benowitz, N. L., Bernert, J. T., Caraballo, R. S., Holiday, D. B., & Wang, J. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn301 · Cited by 684
Self-citation
Research works printed but not linked: 1
- International Agency for Research on Cancer., 2007, Smokeless tobacco and tobacco-specific nitrosamines, 41
Cited by
Sorted by citations
Items 301–400 of 621
Pandya, A., Mythri, K., Mishra, S., & Bajaj, K. (2023) · JMIR Formative Research · doi:10.2196/51658 · Cited by 5
“The retention rate of 58% was higher than the 54% typically obtained in web-based cessation trials [30,31] but quite less than the retention rates (85% and 84”
BackgroundRigotti, N. A., Kelley, J. H. K., Regan, S., Inman, E. M., Kalkhoran, S. M., Flaster, A., & Chaguturu, S. K. (2020) · Preventive Medicine · doi:10.1016/j.ypmed.2020.106216 · Cited by 5
Progress in Treating Youth Smoking: Imperative, Difficult, Slow
Piper, M. E., Mermelstein, R. J., & Baker, T. B. (2019) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2019.3541 · Cited by 5
Self-citationSmoking as a Target for Prevention of Diabetes
Yang, Y., & Sohn, T. S. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0126 · Cited by 5
Williams, P. P., Huddlestone, L., Shoesmith, E., Brady, S., Mitchell, A. S., Exley, V., Wiggins, F., Sinclair, L., Pervin, J., Horspool, M. J., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-094441 · Cited by 4
“We will review the suitability and definitions of the two core smoking-related outcome measures, as per current debate in the field, 35 as follows: for 7-day point prevalence abstinence, we will review and potentially adjust down-ward the CO threshold of <10 ppm for biochemical validation,…”
Automated Tobacco Cessation Intervention for Parents in Pediatric Primary Care
Nabi-Burza, E., Jenssen, B. P., Jeffers, A., Ramachandran, J., Thayer, J. G., Walters, B. H., Levy, D. E., Grundmeier, R. W., Drouin, O., Vangel, M. G., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.29384 · Cited by 4
See, J. J.-H., & See, K. C. (2020) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.20.134 · Cited by 4
“[20] showed that the biochemical verification of abstinence appears to be increasingly important, as social norms and other personal factors affect the accuracy of reporting of smoking behaviour.”
BackgroundVidrine, J. I., Fennell, B. S., Simmons, V. N., Sutton, S. K., Jones, S. R., Woodward, H. W., Hoogland, C. E., & Vidrine, D. J. (2023) · BMC Public Health · doi:10.1186/s12889-023-16189-3 · Cited by 4
“This follows recommendations for community-based smoking cessation trials that do not involve in-person assessments [29, 30].”
BackgroundMethodBhatt, G., Goel, S., Kumar, S., Patial, A., Medhi, B., Grover, S., Attri, S. V., Kaur, R., Singh, G., & Gill, S. S. (2024) · Psychology and Health · doi:10.1080/08870446.2024.2333896 · Cited by 4
“Apart from increasing scientific rigour and validity, biochemical confirmation of cessation is critical in studies where socio-cultural beliefs, norms, and individual attributes affect the reporting of tobacco use status (Benowitz et al., 2020).”
Noonan, D., Silva, S. G., Fish, L. J., Simmons, L. A., Nwankwo, N., Scherr, K. A., Costa, M. D., Sang, E., Sanders, C., Swinkels, C., et al. (2024) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntae182 · Cited by 4
Shi, C., Yang, L., Zeng, G., Cao, H., Yu, F., Sha, S., & Wang, Y. (2024) · BMC Public Health · doi:10.1186/s12889-024-19863-2 · Cited by 4
“1 Flowchart of the participant selection process tobacco smoke exposure [16].”
BackgroundPalmer, A. M., Sutton, S. K., Correa, J. B., Simmons, V. N., & Brandon, T. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247867 · Cited by 4
“Biochemical verification is logistically and financially challenging, especially in nationwide trials like our parent study [15].”
BackgroundSecondhand smoke exposure in school children in Malta assessed through urinary biomarkers
Aquilina, N. J., Jacob, P., Benowitz, N. L., Fsadni, P., & Montefort, S. (2021) · Environmental Research · doi:10.1016/j.envres.2021.112405 · Cited by 4
Self-citationExploring Young Adults’ Beliefs About Cigar Smoking by Susceptibility: A Belief Elicitation Study
Phan, L., Seyl, C. E., Chen-Sankey, J. C., Niederdeppe, J., Guy, M. C., Sterling, K. L., & Choi, K. (2023) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntad088 · Cited by 4
Valter, R., Guyonvarch, O., Allagbé, I., & Faou, A.-L. L. (2023) · Preventive Medicine · doi:10.1016/j.ypmed.2023.107585 · Cited by 4
Martínez-Vispo, C., López‐Durán, A., Suárez-Castro, D., Barroso-Hurtado, M., & Becoña, E. (2023) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-023-10096-y · Cited by 4
“Participants were consid - ered non-smokers if they reported no smoking and had an expired CO ≤ 5 ppm (particles per million) (Benowitz et al., 2019).”
Prell, C., Hébert-Losier, A., Filion, K. B., Reynier, P., & Eisenberg, M. J. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-071099 · Cited by 4
Hudson, D., Howarth, N., Idalsoaga, F. J., Song, Y. N., Islam, A. H., Theiventhiran, S., Díaz, L. A., & Arab, J. P. (2024) · Current Hepatology Reports · doi:10.1007/s11901-024-00630-1 · Cited by 4
“Accurately assessing smoking status is challenging, and further research is needed to validate biomarkers [96].”
Moss-Alonso, E., Martínez-Vispo, C., López‐Durán, A., & Becoña, E. (2024) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-024-01317-w · Cited by 4
“Additionally, smoking cessation literature suggests that when in-person contact is not feasible, self-reported abstinence seems to be a reliable measure (Benowitz et al., 2020; West et al., 2005).”
Robinson, L., Didier, N. A., Thomas, R., Vena, A. A., & King, A. C. (2024) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001864 · Cited by 6
Behavioral Activation mHealth Application for Smoking Cessation: A Randomized Controlled Pilot Trial
Heffner, J. L., Serfozo, E., Baker, K., Gasser, M. L., Watson, N. L., Daughters, S. B., Becoña, E., & McClure, J. B. (2024) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntae137 · Cited by 6
Patterns and Correlates of Multiple tobacco Product use Among people With HIV in India
Nagawa, C. S., Selvamuthu, P., Kumarasamy, N., Faith, B., Rigotti, N. A., & Kruse, G. R. (2024) · Tobacco Use Insights · doi:10.1177/1179173x241303587 · Cited by 4
Smoking impairs cognitive function through the mediating effect of periodontitis in older adults
Luan, X., Zhou, J., Xia, S., Li, J., An, Y., Gao, J., Wang, S., Xia, H., Pan, S., Zhang, Y., et al. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06699-2 · Cited by 4
“The level of serum cotinine, a metabolite of nicotine, was also used as an indicator of tobacco exposure [47].”
González‐Roz, A., Secades‐Villa, R., García–Fernández, G., Loredo, V. M., & Pérez, F. A. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108808 · Cited by 4
Romero, D. R., Pulvers, K. M., Carter, E., Barber, C. A., Satybaldiyeva, N., Novotny, T. E., & Oren, E. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182211857 · Cited by 4
Kalkhoran, S. M., Streck, J. M., Kruse, G. R., Rigotti, N. A., Perez, G. K., Regan, S., Ponzani, C. J., Muzikansky, A., Park, E. R., & Ostroff, J. S. (2022) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntac031 · Cited by 4
Patterson, J. G., Borger, T. N., Burris, J. L., Conaway, M. R., Klesges, R. C., Ashcraft, A. M., Hauser, L., Clark, C., Wright, L., Cooper, S., et al. (2022) · Addiction Science & Clinical Practice · doi:10.1186/s13722-022-00295-5 · Cited by 5
“Also, biochemical verification of smoking status is not always needed in pragmatic randomized control trials [55] and has lower response rates than self-report data [56].”
BackgroundRiley, E. D., Kazi, D. S., Coffin, P. O., Vittinghoff, E., Wade, A. N., Bulfone, T. C., Lynch, K. L., Atai, Z., & Wu, A. H. B. (2022) · Biomarkers · doi:10.1080/1354750x.2022.2129451 · Cited by 4
Mahabee‐Gittens, E. M., Matt, G. E., Jandarov, R., & Merianos, A. L. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20095639 · Cited by 4
“COT is measurable in the urine, saliva, blood, hair, and nails of exposed children who live with smokers and nonsmokers [3], and it has a half-life of approximately 16 h [5,9]; thus, COT levels reflect recent TSE.”
BackgroundMcClure, E. A., Baker, N. L., Walters, K. J., Tomko, R. L., Carpenter, M. J., Bradley, E., Squeglia, L. M., & Gray, K. M. (2023) · JMIR Formative Research · doi:10.2196/47662 · Cited by 4
“Two CO samples per day were deemed necessary to adequately characterize smoking, abstinence, and relapse given the approximate 12-hour half-life of breath CO [40].”
BackgroundMethodAdverse Childhood Experiences and Electronic Cigarette Use among U.S. Young Adults
Olaniyan, A., Nabors, L., King, K. A., & Merianos, A. (2023) · Toxics · doi:10.3390/toxics11110907 · Cited by 3
Clinical Evaluation of a New Smoking Cessation Approach: An Intervention Study
Mohammed, A. M., & Hashish, A. F. (2022) · International Journal of Health Sciences and Research · doi:10.52403/ijhsr.20220920 · Cited by 4
“Cotinine is the main metabolite of nicotine and has longer half-life with relatively high sensitivity and specificity; compared to expiratory a CO level which has short half-life (2h), so urinary cotinine is a reliable indicator of recent nicotine intake [37].”
BackgroundZylva, R. D., Mortimer, E. K., Miller, E. R., Tsourtos, G., Lawn, S., Wilson, C. J., Karnon, J. D., Woodman, R. J., & Ward, P. (2023) · Addiction Science & Clinical Practice · doi:10.1186/s13722-022-00355-w · Cited by 6
Harrell, P. T., England, K. J., Barnett, T. E., Simmons, V. N., Handel, R. W., & Paulson, A. C. (2024) · Tobacco Use Insights · doi:10.1177/1179173x241266563 · Cited by 3
Asfar, T., Lee, D. J., Alcaide, M. L., Jones, D. L., Zvolensky, M. J., Oluwole, O. J., Pan, Y., Brewer, J. A., & Carrico, A. W. (2025) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaf077 · Cited by 3
Sünkel, E. T., Neubert, M., Machulska, A., & Klucken, T. (2025) · Trials · doi:10.1186/s13063-025-08917-4 · Cited by 3
Palo, M. P. D., Spirito, F. D., Garofano, M., Sorbo, R. D., Caggiano, M., Giordano, F., Bartolomeo, M. D., Pessolano, C., Giordano, M., Amato, M., et al. (2025) · Healthcare · doi:10.3390/healthcare13172125 · Cited by 3
“Indeed, smoking cessation effectiveness, as self-reported, was considered a valuable means in large-population-based clinical trials [71].”
InfluentialSchick, M. R., Baker, N. L., Hood, C. O., Tomko, R. L., Gray, K. M., Ramakrishnan, V., Saladin, M. E., & McClure, E. A. (2023) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntad132 · Cited by 3
Gollan, J. K., Liverant, G. I., Jao, N. C., Lord, K. A., Whitton, A. E., Hogarth, L., Fox, E. N., Bauer, A., Quinn, M. H., Pizzagalli, D. A., et al. (2023) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntad221 · Cited by 4
Inflammatory marker levels in children with tobacco smoke exposure
Mahabee‐Gittens, E. M., Matt, G. E., Mazzella, M. J., Doucette, J. T., Ratnani, P., & Merianos, A. L. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156448 · Cited by 3
Wang, Y., Shen, T., & Wang, Y. (2024) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-023-08427-6 · Cited by 3
“Cotinine concentration in serum, with the threshold value of 14 ng/mL, was applied to determine the smoke exposure (active or passive smoking) [23].”
Bizier, A., Jones, A., Businelle, M. S., Kezbers, K. M., Hoeppner, B. B., Giordano, T. P., Thai, J. M., Charles, J. J., Montgomery, A., Gallagher, M. W., et al. (2024) · JMIR Research Protocols · doi:10.2196/52090 · Cited by 3
“This is consistent with best practices as well as most published smoking cessation RCTs (refer to the clinical practice guidelines) [54,67].”
ResultMagodoro, I. M., Aluoch, A. O., Claggett, B. L., Nyirenda, M., Siedner, M. J., Wilkinson, K. A., Wilkinson, R. J., & Ntusi, N. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae568 · Cited by 3
“We defined tobacco exposure as “none” if serum cotinine was 10 ng/mL, “passive exposure or light smoker” if ≥ 10 and 300 ng/mL, and “heavy smoker” if ≥ 300 ng/mL [25].”
BackgroundMangrio, F. A., Uthis, P., Rojnawee, S., & Matthews, A. K. (2025) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2024.0320 · Cited by 3
“Therefore, biochemical verification remains the gold standard for rigorously evaluating the effectiveness of smoking cessation interventions [45].”
USSHER, M. H., Lewis, S., Marczylo, T. H., Blount, B., Brown, J., Bailey, A., Coleman, T. J., Cooper, S. E., Marks, J., George, M., et al. (2025) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaf103 · Cited by 3
Association between biomarkers of tobacco consumption and lung cancer risk among daily smokers
González‐Marrón, A., Martín‐Sánchez, J. C., Pérez‐Ortuño, R., Fu, M., Ballbè, M., Cartanyà‐Hueso, À., Santander, N. M., Pascual, J. A., Fernández, E., & Martínez-Sánchez, J. M. (2021) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2022.1993064 · Cited by 3
Nicotine, Tobacco Smoking, and E-Cigarettes
Ditre, J. W., LaRowe, L. R., Powers, J. M., & Hooker, J. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818697-8.00125-4 · Cited by 3
Snozek, C. L. H., McMillin, G. A., Nwosu, A., Dizon, A., & Krasowski, M. D. (2022) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2022-0094-cp · Cited by 3
Kruse, G. R., Joyce, A., Yu, L., Park, E. R., Neil, J. M., Chang, Y., & Rigotti, N. A. (2023) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2022.208930 · Cited by 3
Salloum, R. G., Bricker, J. B., Lee, J., Theis, R. P., Pluta, K., Williams, M. P., Naous, J., Mulani, S. R., Cogle, C. R., Rubin, D. A., et al. (2023) · Contemporary Clinical Trials · doi:10.1016/j.cct.2023.107120 · Cited by 3
Gordon, J. S., Armin, J. S., Giacobbi, P. R., Hsu, C., Marano, K. M., & Sheffer, C. E. (2023) · JMIR Research Protocols · doi:10.2196/48898 · Cited by 4
“A cutoff of 6 parts per million is recommended [39].”
Reliability of Electronic Health Records in Recording Veterans’ Tobacco Use Status
Sun, D. Q., Basi, J., Kreinbrook, J., Mhaskar, R. S., & Leonelli, F. M. (2023) · Military Medicine · doi:10.1093/milmed/usad290 · Cited by 3
Walker, N. K., Calder, A. J., Barnes, J., Laking, G. R., Parag, V., & Bullen, C. (2023) · BMC Public Health · doi:10.1186/s12889-023-16665-w · Cited by 4
“The primary outcome measure is six-month CA (Rus-sell Standard) defined as self-report of smoking not more than five cigarettes from the Quit date, supported by biochemical validation [30, 31].”
MethodHoeppner, B. B., Eddie, D., Schick, M. R., Hoeppner, S. S., Kelly, L. M., & Kelly, J. F. (2024) · The European Journal of Psychiatry · doi:10.1016/j.ejpsy.2023.100247 · Cited by 3
Weng, X., Yin, H., Liu, K., Song, C., Xie, J., Guo, N., & Wang, M. P. (2024) · JMIR Research Protocols · doi:10.2196/58636 · Cited by 3
Lydom, L. N., Lauridsen, S. V., Liljendahl, M. S., Schmedes, A., Joensen, U. N., & Tønnesen, H. (2025) · Cancers · doi:10.3390/cancers17040713 · Cited by 3
“CO has a short half-life and reflects recent smoking [28,29].”
InfluentialHigh Frequency and Low Intensity Transcranial Magnetic Stimulation for Smoking Cessation
Ponciano‐Rodríguez, G., Chávez-Castillo, C. A., Ríos-Ponce, A. E., & Villafuerte, G. (2021) · Journal of Addiction · doi:10.1155/2021/9988618 · Cited by 3
“To evaluate smoking cessation, subjects performed a weekly determination of exhaled carbon monoxide (CO) with a carbon monoxide analyzer using as cutoff points values below 10 ppm to determine smoking cessation [20] (Bedfont Scientific Ltd.”
MethodMessaging to prevent and reduce young adults’ waterpipe tobacco smoking: A randomized trial
Keller-Hamilton, B. L., Stevens, E. M., Villanti, A. C., Leshner, G., Wagener, T. L., & Mays, D. M. (2022) · Addictive Behaviors · doi:10.1016/j.addbeh.2022.107546 · Cited by 3
Magodoro, I. M., Aluoch, A. O., Claggett, B. L., Nyirenda, M., Siedner, M. J., Wilkinson, K., Wilkinson, R., & Ntusi, N. (2024) · medRxiv · doi:10.1101/2024.03.10.24304039 · Cited by 3
Correa-Fernández, V., Blalock, J. A., Piper, M. E., Canino, G., & Wetter, D. W. (2023) · JMIR Research Protocols · doi:10.2196/44146 · Cited by 2
“Seven-day point prevalence and continuous abstinence will be reported following the Society for Research on Nicotine and Tobacco guidelines [53,54].”
MethodSelf-citationLee, S.-W., Yu, P.-C., Yen, T., Hsu, C., Lai, L.-J., Chen, I., & Chang, T. (2024) · Tobacco Induced Diseases · doi:10.18332/tid/191247 · Cited by 2
“This approach is supported by previous research, demonstrating the effectiveness of exhaled CO levels in distinguishing smokers from non-smokers 16 .”
MethodResultDeterminants of persistent smoking among breast cancer survivors
Gali, K., Aryal, S., Bokemeyer, F., Behrens, S., Seibold, P., Obi, N., Becher, H., & Chang-Claude, J. C. (2024) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2024.102913 · Cited by 2
Su, X., Wong, V., Cheung, Y. T. D., Chan, H. C.-H., Wong, G. N.-T., Lee, J. K. H., Ho, S. Y., Wang, M. P., & Luk, T. T. (2024) · Digital Health · doi:10.1177/20552076241291709 · Cited by 2
Huang, X., Hao, X., Wang, T., Zhang, X., Wu, P., Shen, L., Yang, Y., Zhang, W., & Zhang, K. (2025) · BMC Public Health · doi:10.1186/s12889-024-21173-6 · Cited by 4
“Currently, cotinine is considered a sensitive biomarker of smoking exposure, especially within the past 72 h [25, 26].”
Allagbé, I., Servier, C., & Faou, A.-L. L. (2025) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2025.03.002 · Cited by 2
Magodoro, I. M., Ntusi, N., Jao, J. K., Zar, H. J., Claggett, B. L., Siedner, M. J., Wilkinson, K. A., & Wilkinson, R. J. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf194 · Cited by 2
“Serum cotinine, a nicotine biomarker, assessed tobacco smoke exposure from primary and secondhand smoking [28].”
Edwards, K. C., Garcia-Rosales, K. V., Goniewicz, M. L., Ashley, D. L., Hatsukami, D. K., Wang, L., Feng, J., Blount, B. C., Sharma, E., Merrill, L. S., et al. (2025) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaf083 · Cited by 2
Kunutsor, S. K., Rikhtehgaran, R., Touw, D. J., Dullaart, R. P. F., & Bakker, S. J. L. (2025) · Journal of Human Hypertension · doi:10.1038/s41371-025-01073-x · Cited by 2
Li, Y., Wan, X., & Long, W. (2025) · Tobacco Induced Diseases · doi:10.18332/tid/208426 · Cited by 2
“Cotinine, a metabolite of nicotine, can indicate whether a person is currently smoking, or has been exposed to tobacco smoke in the environment 18 .”
Tang, J., Liu, X., Chen, S., Sun, Y., Zhu, M., Zhou, Z., Liu, Y., Yang, J., Chen, W., & Liao, Y. (2025) · Addiction · doi:10.1111/add.70239 · Cited by 2
“The urinary cotinine cut-off level of 200 ng/mL might overestimate verification rates [32].”
Lin, Y.-S., Morozov, V., & Wu, K. (2025) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2025.114721 · Cited by 2
Zhao, S. Z., Li, M. Y., Li, Y. J., Luk, T. T., Cheung, D. Y. T., Lai, A. Y. K., Tong, H. S. C., Lai, V., Lam, T. H., & Wang, M. P. (2026) · Thorax · doi:10.1136/thorax-2025-224130 · Cited by 2
“36 The main secondary outcome was validated 7-day abstinence at 3 months post-baseline.”
Mobile Chat Messaging for Smoking Relapse Prevention
Luk, T. T., Su, X., Wong, V., Chan, H. C.-H., Wong, G. N.-T., Lee, J. K. H., Ho, S. Y., Lam, T. H., Cheung, Y. T. D., & Wang, M. P. (2026) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.7439 · Cited by 2
Raj, S., Shabil, M., Sachdeva, M., & Goel, S. (2026) · Annals of Epidemiology · doi:10.1016/j.annepidem.2026.110059 · Cited by 2
McClure, E. A., Baker, N. L., Tomko, R. L., Walters, K. J., Chapman, E. K., Carpenter, M. J., & Gray, K. M. (2026) · Addiction · doi:10.1111/add.70382 · Cited by 2
“Cotinine is a metabolite of nicotine and captures use or abstinence from all nicotine products (i.e. is not specific to cigarettes) [41].”
Kim, J., Lee, E., Hwang, D., Ko, A. J., & Park, E. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1755259 · Cited by 2
“Urinary cotinine, the preferred biomarker of nicotine exposure, can detect undisclosed current smoking status over the previous 2–3 days (35).”
Hurley, S. E., Castorina, R., Sultana, D., Thompson, M., Jarmul, S., Gunier, R. B., Nirula, A., Ortiz-Pivaral, L., Jacob, P., She, J., et al. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1789602 · Cited by 2
Self-citationElectrochemical Sensing of Nicotine Using Poly(Safranine)/MoS 2 Nanocomposite Modified Electrode
Narayanan, N., Sharif, S. I. U., Sridharan, G., Atchudan, R., Arya, S. K., & Sundramoorthy, A. K. (2026) · Analytical Letters · doi:10.1080/00032719.2026.2682376 · Cited by 2
“Reliable determination of NIC concentration is therefore essential for toxicological evaluation, quality control of commercial products, and enforcement of regulatory standards (Benowitz et al. 2020).”
Rojewski, A. M., Fucito, L. M., Baker, N. L., Palmer, A. M., Foster, M. G., Warren, G. W., Bernstein, S. L., & Toll, B. A. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-051226 · Cited by 4
Role of untargeted omics biomarkers of exposure and effect for tobacco research
Shields, P. G. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100098 · Cited by 2
“Profiling can be focused on a priori hypotheses, for example in tobacco research this can assess pathways known to be involved in carcinogenesis as hallmarks of cancer [1], or xenobiotic metabolism of carcinogens and other toxicants.”
BackgroundEdwards, K. C., Khan, A., Sharma, E., Wang, L., Feng, J., Blount, B. C., Sosnoff, C. S., Smith, D. M., Goniewicz, M. L., Pearson, J., et al. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-1228 · Cited by 2
Zhang, M. J., He, W. J. A., Luk, T. T., Wang, M. P., Chan, S. S. C., & Cheung, Y. T. D. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1147096 · Cited by 2
Pope, I., Suresh, C., Ward, E., Belderson, P., & Notley, C. J. (2023) · Tobacco Use Insights · doi:10.1177/1179173x231193898 · Cited by 2
Lee, H., Chun, M., & Lee, S. (2023) · Molecules · doi:10.3390/molecules28237685 · Cited by 2
“Urinary biomarkers can be analyzed by a variety of analytical methods, including immunoassay, gas chromatography (GC), GC-mass spectrometry (GC-MS), liquid chromatography (LC), and liquid chromatography with tandem mass spectrometry (LC-MS/MS) [4].”
BackgroundMethodInfluentialArumugam, M., Sundaram, R. L., Jayajothi, V., Arul, M., Suresh, J. A., & Kesavan, S. K. (2023) · Advances in Redox Research · doi:10.1016/j.arres.2023.100089 · Cited by 4
Associations between morning affect and later-day smoking urges and behavior.
Benson, L., Chen, M., Torre, I. D. L., Hébert, E. T., Alexander, A. C., Ra, C. K., Kendzor, D. E., & Businelle, M. S. (2023) · Psychology of Addictive Behaviors · doi:10.1037/adb0000970 · Cited by 2
Lara, D., Alaniz-Cantú, E. I., Siddalingaiaha, S., Oliveira, I., Chávez‐Iñiguez, A., DeJesus, E., Fuller, D., Márquez, D. X., Vásquez, E., Li, D., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0519 · Cited by 2
“However, self-reported smoking abstinence has been judged to be appropriate for minimal contact community interventions that do not involve face-to-face contact (60).”
BackgroundZhang, M. J., Cheung, Y. T. D., Wang, Q., Cheng, C. C. W., Luk, T. T., He, W. J. A., Wang, M. P., & Lam, T. H. (2024) · Tobacco Induced Diseases · doi:10.18332/tid/187839 · Cited by 3
“The second stage required participants to abstain from tobacco products for at least 9 hours, given that the half-life of exhaled CO varies from 2 to 8 hours 21 .”
BackgroundPoliakova, N., Shrier, L. A., Harris, S. K., & Bélanger, R. E. (2024) · Tobacco Use Insights · doi:10.1177/1179173x241259603 · Cited by 2
Domić, A., Pilipović-Broćeta, N., Grabež, M., Divac, N., Igic, R. P., & Škrbić, R. (2024) · Medicina · doi:10.3390/medicina60060965 · Cited by 2
“Such experiences have been described in the literature, but there is currently not enough scientific evidence for routines to be applied [40] Self-assessment tests of smoking status, the FTND, and biochemical validation [41] help to make smoking cessation successful [42].”
BackgroundAgterberg, S., Shuter, J., Stanton, C. A., Seng, E. K., & Weinberger, A. H. (2024) · AIDS Care · doi:10.1080/09540121.2024.2373403 · Cited by 2
“Smoking abstinence was assessed as dichotomous (abstinent vs. not abstinent) and self-reported 7-day point prevalence smoking abstinence was biochemically con fi rmed based on an exhaled carbon monoxide level of ≤ 6 parts per million (ppm) (Benowitz et al., 2020).”
Kaldal, A., Tonstad, S., & Jortveit, J. (2024) · Tobacco Prevention & Cessation · doi:10.18332/tpc/191843 · Cited by 2
Weng, X., Song, C., Liu, K., Zhao, S. Z., Yang, H., & Wang, M. P. (2024) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntae230 · Cited by 2
Gupte, H., Kruse, G. R., Chang, Y., Jagiasi, D., Pradhan, S., & Rigotti, N. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0312319 · Cited by 2
Brown, E., Smith, D. M., & Armitage, C. J. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209610 · Cited by 2
Schiek, H., Esch, T., & Hoetger, C. (2025) · BMC Digital Health · doi:10.1186/s44247-025-00147-7 · Cited by 4
“Future research should consider incorporating biochemical verification methods to enhance the validity and reliability of smoking abstinence assessments [66].”
Michaud, T. L., Puga, T. B., Archer, R., Theye, E., Zagurski, C., Estabrooks, P. A., & Dai, H. D. (2025) · JMIR Research Protocols · doi:10.2196/60527 · Cited by 2
Brett, E. I., Slear, J. H. K., Goniewicz, M. L., & King, A. C. (2025) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-24-1789 · Cited by 2
Hoogland, C. E., Sutton, S. K., Fennell, B. S., Simmons, V. N., Vinci, C., Naqa, I. E., Salloum, R. G., Shete, S. S., Hembree, T. N., Vidrine, D. J., et al. (2025) · AJPM Focus · doi:10.1016/j.focus.2025.100361 · Cited by 2
“26”
Kim, B. J. (2025) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2025.5.e10 · Cited by 2
Metadata
- Authors
- Benowitz, N. L., Bernert, J. T., Foulds, J., Hecht, S. S., Jacob, P., Jarvis, M. J., Joseph, A., Oncken, C., & Piper, M. E.
- Affiliations
- University of California, San Francisco (US)
- Centers for Disease Control and Prevention (US)
- Pennsylvania State University (US)
- University of Minnesota (US)
- University College London (GB)
- University of Connecticut (US)
- University of Wisconsin–Madison (US)
- Corresponding author
- Benowitz, Neal L
- ORCID
- Venue
- Nicotine & Tobacco Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-10-01
- Volume
- 22
- Issue
- 7
- Pages
- 1086-1097
- ISSN
- 1462-2203 (ISSN-L)
- 1469-994X
- PMC
- PMC7882145
- OpenAlex
- W2978389675
- Cited by
- 619
- References
- 121
- Citations by year
- 2026: 99 · 2025: 84 · 2024: 107 · 2023: 103 · 2022: 87 · 2021: 79 · 2020: 54 · 2019: 4
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Nicotine & Tobacco Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (CC999999)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Keywords
- tobacco use, smoking abstinence, biomarkers, cotinine, carbon monoxide, electronic cigarettes, NNAL, biological specimen, detection window
- MeSH terms
- Cigarette Smoking, Carbon Monoxide, Cotinine, Humans, Nicotine, United States, Biomarkers, Smoking Cessation, Tobacco Products
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review